Source: Media Outreach
SINGAPORE – Media OutReach – 3 March 2021 – Cordlife Group Limited, a consumer healthcare company announced today that the Ministry of Health has issued a license permitting the Company to launch OptiQ, a corneal lenticule banking service in Singapore. Cordlife is the first company in Asia to let patients undergoing refractive eye surgery using lenticule extraction method (e.g. SMILE) for myopia or astigmatism to cryopreserve their corneal lenticules for potential treatment of presbyopia and other ocular conditions in the future.
The technology behind OptiQ was invented by Professors Donald Tan and Jodhbir Mehta from Singapore Eye Research Institute (“SERI”), the research arm of Singapore National Eye Centre (“SNEC”).
Singapore launches first bank in Asia for eye surgery patients to freeze piece of corneal tissue for future use straitstimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from straitstimes.com Daily Mail and Mail on Sunday newspapers.
Died: November 12, 2020. PROFESSOR Wallace Stewart Foulds, who has died aged 96, was an internationally renowned ophthalmologist who gave his grateful patients the precious gift of sight, earning the eternal thanks and respect of them and their families. Rarely was that more in evidence when, having stepped off a flight at London’s Heathrow, he was stopped at customs and asked to open his case. Peering inside, the customs official spotted the name and address label, and immediately closed the case. “It’s a pleasure to meet you Professor Foulds,” he said. “You saved the sight of my uncle in India 25 years ago and are regarded as a hero by our family.”
TX ), a wholly-owned subsidiary of SGX Mainboard-listed Thomson Medical Group Limited (the
Group ), today announced a strategic partnership with Plano Pte Ltd (
Plano ), a Singapore-based HealthTech startup. The collaboration will leverage on the respective strengths of TX and Plano to address and manage the rapidly increasing incidence of myopia through innovative technological solutions.
Myopia is steadily growing into one of the biggest public health challenges in the world, affecting an estimated 2.6 billion people globally, or about one-third of the world s population. By 2050, myopia is projected to affect 5 billion people, which is estimated to be about half of the world s population
Optomed has established a Scientific Advisory Board
News provided by
Share this article
Share this article
HELSINKI, Jan. 28, 2021 /PRNewswire/ Optomed has established an international scientific advisory board. The board consists of globally recognized and scientifically merited medical doctors specializing in ophthalmology and neuro-ophthalmology, with advanced experience on artificial intelligence applied to detection of ophthalmic conditions.
The scientific advisory board consists of the following members:
Robert Chang, MD, Associate Professor of Ophthalmology, Stanford University Medical Center, USA
Nina Hautala, MD, PhD, Professor of Ophthalmology, Oulu University Hospital, Finland
Dan Milea, MD, PhD, Professor of Ophthalmology, Head, Visual Neuroscience Group, Singapore Eye Research Institute, Singapore National Eye Centre and Duke-NUS Medical School, Singapore